Scalpa Inc. 2021-01-14 Health safe CPSC
Health · CPSC · Recall #CPSC-21719
Scalpa Numb Maximum Strength Topical Anesthetic Cream Recall
Issued January 14, 2021 · Scalpa Inc. · 10,000 units affected
In January 2021, Scalpa Inc. recalled the Scalpa Numb Maximum Strength Topical Anesthetic Cream, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.
What you should do
- 1 Stop using Scalpa Numb Maximum Strength Topical Anesthetic Cream right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Scalpa Inc. to arrange your refund. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Refund): Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.
Recall details
- Brand
- Scalpa Inc.
- Category
- Health
- Recall date
- January 14, 2021
- Units affected
- 10,000
- Sold at
- Scalpashop.com and Amazon.com from February 2020 through November 2020 for about $18.
- Recall number
- CPSC-21719
- Made in
- China
- Issuing agency
- CPSC
In context
- Scalpa Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 10,000 units is enough to reach roughly 1 in every 13,100 US households.
- This is the 7th Health recall we've logged in 2021.